- -- Quick Links --
-
- Home
- The focus
- Organizers
- FABA
- Pharmexcil
- Industry Speak
- BioAsia 2012
- BioAsia 2011
- BioAsia 2010
- BioAsia 2009
- Proceedings 2012
- Proceedings 2011
- Proceedings 2010
- Proceedings 2009
- Awards-2012
- Awards-2011
- Awards-2010
- Awards-2009
- Photo Gallery 2012
- Photo Gallery 2011
- Photo Gallery 2010
- Photo Gallery 2009
- Video Gallery 2012
- Video Gallery 2011
- Presentation
- Publications
- Contact Us
About BioAsia
About BioAsia
Focus
Biotechnology being an emerging industry, game-changing strategies and relevant application of the knowledge-intelligence resource pool, drive the process of growth. BioAsia seeks to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the industry by offering a vibrant global platform for convergence of the key stakeholders - Biotech & Biopharma Companies, research institutions, investors, service providers, policy makers, regulators and analysts.With an objective of optimizing the immense business potential of biotech, BioAsia enables an effective environment for fostering collaborations, joint ventures, M&As that has increasingly become an integral part of industry growth agenda. BioAsia also provides a dynamic platform for companies to exhibit, launch and showcase their unique strengths, products and services. As an entity committed to the promise of Biotechnology, BioAsia encourages knowledge and experience sharing amongst industry players, academia, young research scientists to promote innovations and initiatives through appropriate awards and recognitions. In addition, by creating a dynamic coterie of experience sharing from global industry thought leaders and through panel discussions, BioAsia is committed to play a key role in advocating issues to the policy makers and in chartering the road-map ahead.
BioAsia is your Asian gateway in both directions (inward & outward) to explore the immense potential of Biotechnology. On a larger level, BioAsia partners with you to drive a global transformation from the treatment of illness to wellness.
Industry Speak
Dr. Seth Berkley, CEO, GAVI Alliance
India is a prime example of how the vaccine landscape has changed over the past 20 years....
Dr. Krishna M. Ella, CMD, Bharat Biotech International Ltd., Hyderabad
Dr. K V Balasubramaniam, Managing Director, Indian Immunologicals Ltd.
More professionally conducted this time with better industry participation
Dr. Krishna M. Ella, CMD, Bharat Biotech International Ltd., Hyderabad
Vishal Gandhi, SVP and Head- Life Sciences, Yes Bank
Roopesh Bhargava, Director - Sales & Marketing, Sanofi Pasteur India (Pvt) Ltd., Mumbai
Dr. Shreemanta K Parida, CEO, Vaccine Grand Challenge Program, Dept of Biotechnology, Ministry of Science & Technology, Govt. of India
Dr. Harish Iyer, CEO, Shantha Biotech, Hyderabad
Mr. Manni Kantipudi, Chief Executive Officer, GVK Biosciences
Dr. K V Balasubramaniam, Managing Director, Indian Immunologicals Ltd.
"More professionally conducted this time with better industry participation"